BACKGROUND: Allosensitization can be a significant barrier to transplantation for some patients, and previous studies suggested that pre-transplant allosensitization was associated with worse outcomes after lung transplantation. However, human leukocyte antigen (HLA) antibody testing has evolved significantly over the past 10 years, and current assays are highly sensitive and specific. METHODS: We examined the impact of pre-transplant allosensitization on post-transplant outcomes in the era of solid-phase multiplex HLA antibody detection assays in this retrospective, single-center study of 304 adult transplant recipients between January 1, 2006, and December 31, 2012. We accepted donor organs for allosensitized patients if a virtual crossmatch was compatible with all previously identified antibodies. RESULTS: In univariate and multivariate Cox proportional hazards models, pre-transplant allosensitization, the calculated panel reactive antibody, and the number of pre-transplant HLA antibodies were not associated with the development of acute cellular rejection, lymphocytic bronchiolitis, donor-specific HLA antibodies, chronic lung allograft dysfunction, or graft failure. CONCLUSIONS: Pre-transplant allosensitization does not adversely affect outcomes after lung transplantation when the potentially reactive HLAs are avoided in the donor by a virtual crossmatch with the recipient.
BACKGROUND: Allosensitization can be a significant barrier to transplantation for some patients, and previous studies suggested that pre-transplant allosensitization was associated with worse outcomes after lung transplantation. However, human leukocyte antigen (HLA) antibody testing has evolved significantly over the past 10 years, and current assays are highly sensitive and specific. METHODS: We examined the impact of pre-transplant allosensitization on post-transplant outcomes in the era of solid-phase multiplex HLA antibody detection assays in this retrospective, single-center study of 304 adult transplant recipients between January 1, 2006, and December 31, 2012. We accepted donor organs for allosensitized patients if a virtual crossmatch was compatible with all previously identified antibodies. RESULTS: In univariate and multivariate Cox proportional hazards models, pre-transplant allosensitization, the calculated panel reactive antibody, and the number of pre-transplant HLA antibodies were not associated with the development of acute cellular rejection, lymphocytic bronchiolitis, donor-specific HLA antibodies, chronic lung allograft dysfunction, or graft failure. CONCLUSIONS: Pre-transplant allosensitization does not adversely affect outcomes after lung transplantation when the potentially reactive HLAs are avoided in the donor by a virtual crossmatch with the recipient.
Authors: C L Lau; S M Palmer; K E Posther; D N Howell; N L Reinsmoen; H T Massey; V F Tapson; J J Jaggers; T A D'Amico; R D Davis Journal: Ann Thorac Surg Date: 2000-05 Impact factor: 4.330
Authors: Marc Estenne; Janet R Maurer; Annette Boehler; James J Egan; Adaani Frost; Marshall Hertz; George B Mallory; Gregory I Snell; Samuel Yousem Journal: J Heart Lung Transplant Date: 2002-03 Impact factor: 10.247
Authors: Alin L Girnita; Kenneth R McCurry; Aldo T Iacono; Rene Duquesnoy; Timothy E Corcoran; Mohamed Awad; Kathy J Spichty; Samuel A Yousem; Gilbert Burckart; James H Dauber; Bartley P Griffith; Adriana Zeevi Journal: J Heart Lung Transplant Date: 2004-10 Impact factor: 10.247
Authors: Alin L Girnita; Rene Duquesnoy; Samuel A Yousem; Aldo T Iacono; Timothy E Corcoran; Manuela Buzoianu; Bruce Johnson; Kathy J Spichty; James H Dauber; Gilbert Burckart; Bartley P Griffith; Kenneth R McCurry; Adriana Zeevi Journal: Am J Transplant Date: 2005-01 Impact factor: 8.086
Authors: Denis Hadjiliadis; Cecilia Chaparro; Nancy L Reinsmoen; Carlos Gutierrez; Lianne G Singer; Mark P Steele; Thomas K Waddell; Robert D Davis; Michael A Hutcheon; Scott M Palmer; Shaf Keshavjee Journal: J Heart Lung Transplant Date: 2005-07 Impact factor: 10.247
Authors: Chad A Witt; Joseph P Gaut; Roger D Yusen; Derek E Byers; Jennifer A Iuppa; K Bennett Bain; G Alexander Patterson; Thalachallour Mohanakumar; Elbert P Trulock; Ramsey R Hachem Journal: J Heart Lung Transplant Date: 2013-08-13 Impact factor: 10.247
Authors: J S Gammie; S M Pham; Y L Colson; A Kawai; R J Keenan; R J Weyant; B P Griffith Journal: J Heart Lung Transplant Date: 1997-04 Impact factor: 10.247
Authors: A Jaramillo; M A Smith; D Phelan; S Sundaresan; E P Trulock; J P Lynch; J D Cooper; G A Patterson; T Mohanakumar Journal: Transplantation Date: 1999-04-27 Impact factor: 4.939
Authors: S Sundaresan; T Mohanakumar; M A Smith; E P Trulock; J Lynch; D Phelan; J D Cooper; G A Patterson Journal: Transplantation Date: 1998-03-15 Impact factor: 4.939
Authors: Scott M Palmer; R Duane Davis; Denis Hadjiliadis; Marshall I Hertz; David N Howell; Fran E Ward; Kay Savik; Nancy L Reinsmoen Journal: Transplantation Date: 2002-09-27 Impact factor: 4.939
Authors: Laneshia K Tague; Chad A Witt; Derek E Byers; Roger D Yusen; Patrick R Aguilar; Hrishikesh S Kulkarni; Karen Bennett Bain; Keith A Fester; Varun Puri; Daniel Kreisel; Thalachallour Mohanakumar; Elbert P Trulock; Ramsey R Hachem Journal: Ann Am Thorac Soc Date: 2019-07
Authors: Andrew M Courtwright; Severine Cao; Isabelle Wood; Hari R Mallidi; Jared Kawasawa; Anna Moniodis; Julie Ng; Souheil El-Chemaly; Hilary J Goldberg Journal: Ann Am Thorac Soc Date: 2019-09
Authors: Lorriana E Leard; Are M Holm; Maryam Valapour; Allan R Glanville; Sandeep Attawar; Meghan Aversa; Silvia V Campos; Lillian M Christon; Marcelo Cypel; Göran Dellgren; Matthew G Hartwig; Siddhartha G Kapnadak; Nicholas A Kolaitis; Robert M Kotloff; Caroline M Patterson; Oksana A Shlobin; Patrick J Smith; Amparo Solé; Melinda Solomon; David Weill; Marlies S Wijsenbeek; Brigitte W M Willemse; Selim M Arcasoy; Kathleen J Ramos Journal: J Heart Lung Transplant Date: 2021-07-24 Impact factor: 13.569